Alexandra Hughes-Wilson

Insider Reports History

Entity
Individual
Location
C/O Mereo Biopharma, 1 Cavendish Place, London, United Kingdom
Signature
/s/ Christine Fox, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alexandra Hughes-Wilson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mereo BioPharma Group plc Chief Patient Access and Commercial Planning American Depositary Shares representing Ordinary Shares 50.5K $213K $4.22 Sep 13, 2024 Direct
Mereo BioPharma Group plc Chief Patient Access and Commercial Planning Share Options (Right to buy) 0 $0 $1.01 Sep 11, 2024 Direct
Mereo BioPharma Group plc Chief Patient Access and Commercial Planning Performance Based Restricted Stock Unit 0 Sep 11, 2024 Direct

Insider Reports Filed by Alexandra Hughes-Wilson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MREO Mereo BioPharma Group plc Sep 12, 2024 4 -$637K 4 Sep 16, 2024 Chief Patient Access and Commercial Planning
MREO Mereo BioPharma Group plc Sep 11, 2024 6 $0 4 Sep 13, 2024 Chief Patient Access and Commercial Planning
MREO Mereo BioPharma Group plc Jun 25, 2024 2 -$115K 4 Jun 27, 2024 Chief Patient Access and Commercial Planning
MREO Mereo BioPharma Group plc Jun 21, 2024 2 $0 4 Jun 25, 2024 Chief Patient Access and Commercial Planning
MREO Mereo BioPharma Group plc May 22, 2024 0 $0 4/A Jun 11, 2024 Chief Patient Access and Commercial Planning
MREO Mereo BioPharma Group plc May 22, 2024 8 -$383K 4 May 23, 2024 Chief Patient Access and Commercial Planning
MREO Mereo BioPharma Group plc Jan 25, 2024 1 $0 4 Jan 26, 2024 Chief Patient Access and Commercial Planning
MREO Mereo Biopharma Group plc Jan 1, 2024 0 $0 3 Jan 2, 2024 Chief Patient Access and Commercial Planning Exhibit 24 - Power of Attorney